Facet joint

Premia Spine Announces FDA Breakthrough Device Designation for Its TOPS™ Spinal Arthroplasty System

Retrieved on: 
Wednesday, March 31, 2021
FDA, Surgery, Medical devices, Health, Physical therapy, Facet joint, Joints, Organ systems, Artificial facet replacement

Premia Spine , a medical technology company aiming to change the way debilitating chronic leg and back pain is treated, today announced that its TOPS facet arthroplasty system won Breakthrough Device Designation from the U.S. Food & Drug Administration.

Key Points: 
  • Premia Spine , a medical technology company aiming to change the way debilitating chronic leg and back pain is treated, today announced that its TOPS facet arthroplasty system won Breakthrough Device Designation from the U.S. Food & Drug Administration.
  • View the full release here: https://www.businesswire.com/news/home/20210331005342/en/
    TOPS is the first and only facet joint replacement system for the lumbar spine.
  • FDA recognition of the TOPS System as a Breakthrough Device means Premia Spine will receive feedback throughout the regulatory process, as well as prioritized review by the agency.
  • Premia Spine, a medical technology company, aims to improve the lives of chronic leg and back pain patients with its TOPS System facet arthroplasty system.

Growing Cases of Arthritis and Numerous Cases of Joint Pain Shall Propel the Growth of Global Joint Pain Injections Market, TMR

Retrieved on: 
Tuesday, March 24, 2020
Musculoskeletal system, Medicine, Medical specialties, RTT, Rheumatology, Skeletal disorders, Nociception, Facet joint, Joints, Injection, Arthritis, Elbow

However, the global joint pain injections market is anticipated to be quite lucrative as the market shall rise from US$ 3 Bn in 2018 to US$ 6 Bn in 2026, which is projected to attract new players in the global joint pain injections market.

Key Points: 
  • However, the global joint pain injections market is anticipated to be quite lucrative as the market shall rise from US$ 3 Bn in 2018 to US$ 6 Bn in 2026, which is projected to attract new players in the global joint pain injections market.
  • Explore the latest study on global joint pain injections marketunder the title: Joint Pain Injections Market (Injection Type - Corticosteroid Injections, Hyaluronic Acid Injections; Joint Type - Knee and Ankle, Hip Joint, Shoulder and Elbow, Facet Joints of the Spine; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 2026 at
    Growing prevalence of arthritis and various other bone-related diseases are the major factors that are propelling the growth of global joint pain injections market.
  • Global Joint Pain Injections Market: Regional Analysis
    North America is projected to hold the largest share in the global joint pain injections market.
  • The global joint pain injections market is segmented on the basis of:
    Global Joint Pain Injections Market, Injection Type
    Global Joint Pain Injections Market, Joint Type

Growing Cases of Arthritis and Numerous Cases of Joint Pain Shall Propel the Growth of Global Joint Pain Injections Market, TMR

Retrieved on: 
Tuesday, March 24, 2020
Musculoskeletal system, Medicine, Medical specialties, RTT, Rheumatology, Skeletal disorders, Nociception, Facet joint, Joints, Injection, Arthritis, Elbow

However, the global joint pain injections market is anticipated to be quite lucrative as the market shall rise from US$ 3 Bn in 2018 to US$ 6 Bn in 2026, which is projected to attract new players in the global joint pain injections market.

Key Points: 
  • However, the global joint pain injections market is anticipated to be quite lucrative as the market shall rise from US$ 3 Bn in 2018 to US$ 6 Bn in 2026, which is projected to attract new players in the global joint pain injections market.
  • Explore the latest study on global joint pain injections marketunder the title: Joint Pain Injections Market (Injection Type - Corticosteroid Injections, Hyaluronic Acid Injections; Joint Type - Knee and Ankle, Hip Joint, Shoulder and Elbow, Facet Joints of the Spine; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 2026 at
    Growing prevalence of arthritis and various other bone-related diseases are the major factors that are propelling the growth of global joint pain injections market.
  • Global Joint Pain Injections Market: Regional Analysis
    North America is projected to hold the largest share in the global joint pain injections market.
  • The global joint pain injections market is segmented on the basis of:
    Global Joint Pain Injections Market, Injection Type
    Global Joint Pain Injections Market, Joint Type

Joint Pain Injections Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Retrieved on: 
Thursday, April 25, 2019
Musculoskeletal system, Medical Subject Headings, Medical classification, RTT, Facet joint, Joints, Injection, Elbow, Overuse injuries, Pain, Osteoarthritis

NEW YORK, April 25, 2019 /PRNewswire/ -- Joint Pain Injections Market: Overview

Key Points: 
  • NEW YORK, April 25, 2019 /PRNewswire/ -- Joint Pain Injections Market: Overview
    This report analyzes the current and future scenario of the global joint pain injections market for the period 2018 to 2026.
  • Rise in geriatric population, increased prevalence of joint disorders, and high unmet medical needs are likely to be major drivers of the global joint pain injections market during the forecast period.
  • Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others.In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others.
  • The global joint pain injections market has been segmented as below: